Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$651M |
| 2 |
Monster Beverage
MNST
|
+$615M |
| 3 |
Intercontinental Exchange
ICE
|
+$556M |
| 4 |
Johnson & Johnson
JNJ
|
+$382M |
| 5 |
Applied Materials
AMAT
|
+$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$771M |
| 3 |
Deere & Co
DE
|
+$597M |
| 4 |
Meta Platforms (Facebook)
META
|
+$543M |
| 5 |
Microsoft
MSFT
|
+$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Vanguard FTSE Europe ETF
VGK
$27.1B
| $52.6M | 0.03% |
739,574
-15,576
| -2% | -$1.11M |
|
377
Innospec
IOSP
$2.12B
| $52.4M | 0.03% |
463,411
-90,810
| -16% | -$10.3M |
|
378
Coca-Cola Europacific Partners
CCEP
$40.9B
| $52.4M | 0.03% |
+664,945
| New | +$52.4M |
|
379
Waste Management
WM
$88.2B
| $52.2M | 0.03% |
251,355
-840
| -0.3% | -$174K |
|
380
Nordson
NDSN
$12.7B
| $52.1M | 0.03% |
198,238
+79
| +0% | +$20.7K |
|
381
CG Oncology
CGON
$2.52B
| $51.9M | 0.03% |
1,526,534
+99,517
| +7% | +$3.38M |
|
382
Walmart
WMT
$815B
| $51.8M | 0.03% |
641,111
-153
| -0% | -$12.4K |
|
383
Immunome
IMNM
$818M
| $51M | 0.03% |
3,488,121
+324,614
| +10% | +$4.74M |
|
|
MREO
384
Mereo BioPharma
MREO
$285M
| $50.9M | 0.03% |
12,345,866
+4,464,984
| +57% | +$18.4M |
|
385
The Bancorp
TBBK
$3.49B
| $50.8M | 0.03% |
949,955
-4,375
| -0.5% | -$234K |
|
386
Sanofi
SNY
$114B
| $50.8M | 0.03% |
881,682
+92,015
| +12% | +$5.3M |
|
|
EXE
387
Expand Energy Corporation Common Stock
EXE
$22.5B
| $50.5M | 0.03% |
614,102
+4,600
| +0.8% | +$378K |
|
388
Graphic Packaging
GPK
$6.38B
| $50.2M | 0.03% |
1,697,512
+76,313
| +5% | +$2.26M |
|
389
Williams-Sonoma
WSM
$24.8B
| $49.9M | 0.03% |
322,249
-323,411
| -50% | -$50.1M |
|
390
Royalty Pharma
RPRX
$15.5B
| $49.9M | 0.03% |
1,763,245
-4,172
| -0.2% | -$118K |
|
391
Brady Corp
BRC
$3.79B
| $49.6M | 0.03% |
647,085
-6,670
| -1% | -$511K |
|
|
CRGX
392
DELISTED
CARGO Therapeutics
CRGX
| $49.3M | 0.03% |
2,675,285
+46,659
| +2% | +$860K |
|
393
Wyndham Hotels & Resorts
WH
$6.71B
| $49.1M | 0.03% |
628,521
+27,172
| +5% | +$2.12M |
|
394
Entegris
ENTG
$12.4B
| $48.7M | 0.02% |
432,389
+404
| +0.1% | +$45.5K |
|
395
Clearwater Analytics
CWAN
$5.97B
| $48.2M | 0.02% |
1,906,929
+1,819
| +0.1% | +$45.9K |
|
396
Ball Corp
BALL
$13.9B
| $48M | 0.02% |
707,279
+87,577
| +14% | +$5.95M |
|
397
CVS Health
CVS
$89.1B
| $47.8M | 0.02% |
760,903
+599,200
| +371% | +$37.7M |
|
398
Fortune Brands Innovations
FBIN
$7.29B
| $47.8M | 0.02% |
534,029
-67,892
| -11% | -$6.08M |
|
|
SW
399
Smurfit Westrock plc
SW
$24.4B
| $47.4M | 0.02% |
+945,572
| New | +$47.4M |
|
400
TC Energy
TRP
$53.9B
| $47.3M | 0.02% |
994,077
-226
| -0% | -$10.8K |
|